博时恒生医疗保健ETF发起式联接(QDII)C(014425)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-219,438,114.41 |
750,705,219.46 |
655,068,759.78 |
-203,731,851.51 |
| 利息合计 |
143,140.33 |
638,914.63 |
417,319.97 |
618,077.08 |
| 其中:存款利息收入 |
143,140.33 |
638,914.63 |
417,319.97 |
618,077.08 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
8,981,595.88 |
244,481,844.22 |
17,273,716.00 |
-53,382,104.75 |
| 其中:股票投资收益 |
- |
- |
- |
- |
| 基金投资收益 |
8,981,595.88 |
244,481,153.57 |
17,273,025.35 |
-53,449,444.01 |
| 债券投资收益 |
- |
690.65 |
690.65 |
67,339.26 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
- |
- |
- |
- |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-228,730,785.62 |
504,424,855.08 |
636,789,667.06 |
-151,263,005.03 |
| 其他收入 |
167,935.00 |
1,159,605.53 |
588,056.75 |
295,181.19 |
| 费用 |
1,058,539.80 |
3,147,445.37 |
1,137,837.13 |
1,842,219.11 |
| 管理人报酬 |
162,384.57 |
414,120.22 |
216,080.71 |
361,666.10 |
| 基金托管费 |
48,715.40 |
124,236.03 |
64,824.22 |
108,499.78 |
| 销售服务费 |
703,079.07 |
1,493,875.48 |
678,715.15 |
1,149,675.26 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
102,799.27 |
234,743.02 |
115,877.28 |
222,377.97 |
| 利润总额 |
-220,496,654.21 |
747,557,774.09 |
653,930,922.65 |
-205,574,070.62 |